![Uwe Klein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Uwe Klein
Corporate Officer/Principal bei
SEPTERNA, INC.
Vermögen: 4 Mio $ am 31.07.2026
Profil
Uwe Klein currently works at Septerna, Inc., as Senior Vice President-Biological Sciences from 2021.
Dr. Klein also formerly worked at Theravance Biopharma, Inc., as Senior Director-Molecular & Cellular Biology from 1998 to 2014, Bristol Myers Squibb Co., as Vice President-Biology from 2020 to 2021, MyoKardia, Inc., as Vice President-Biology from 2019 to 2020, and Numerate, Inc., as Vice President-Biology from 2014 to 2019.
Dr. Klein received his undergraduate degree, graduate degree, and doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SEPTERNA, INC. 0,28 % | 06.02.2026 | 127.533 ( 0,28 % ) | 4 Mio $ | 31.07.2026 |
Aktive Positionen von Uwe Klein
| Unternehmen | Position | Beginn |
|---|---|---|
| SEPTERNA, INC. | Corporate Officer/Principal | 01.08.2021 |
Ehemalige bekannte Positionen von Uwe Klein
| Unternehmen | Position | Ende |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.03.2021 |
| MYOKARDIA, INC. | Corporate Officer/Principal | 01.11.2020 |
Numerate, Inc.
 Numerate, Inc. Packaged SoftwareTechnology Services Develops drug engineering platform | Corporate Officer/Principal | 01.09.2019 |
| THERAVANCE BIOPHARMA, INC. | Corporate Officer/Principal | 01.10.2014 |
Ausbildung von Uwe Klein
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
58
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Johann Wolfgang Goethe-Universität Frankfurt am Main
 Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Numerate, Inc.
Numerate, Inc. Packaged SoftwareTechnology Services Develops drug engineering platform | Technology Services |
Theravance Biopharma, Inc.
 Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
Septerna, Inc.
 Septerna, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that discovers and develops G protein-coupled receptor oral small molecule products for the treatment of hypoparathyroidism | Health Technology |
